Vitamin Super B-Complex

DIETARY_SUPPLEMENT4 trials

Sponsors

Romark Laboratories L.C.

Conditions

COVID-19EnterovirusRhinovirusViral Respiratory Illnesses

Phase 3

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)

TerminatedNCT04343248

Romark Laboratories L.C.COVID-19, Viral Respiratory Illnesses

Start: 2020-05-12End: 2021-02-01Updated: 2024-07-08

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

CompletedNCT04359680

Romark Laboratories L.C.COVID-19, Viral Respiratory Illnesses

Start: 2020-05-13End: 2021-04-07Updated: 2024-06-26

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

CompletedNCT04486313

Romark Laboratories L.C.COVID-19

Start: 2020-08-13End: 2021-02-08Updated: 2024-03-29

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

TerminatedNCT04489381

Romark Laboratories L.C.Enterovirus, Rhinovirus

Start: 2020-08-19End: 2021-02-02Updated: 2024-10-17

Related Papers

A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

Frontiers in Medicine2022-09-088 citations

Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)

Trials2022-07-227 citations

A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19.

2022-02-2834 citations

Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.

2021-06-2749 citations